Bevespi Aerosphere Aerosol, Metered
Pricing Report NDC 0310-4600-39

Latest NADAC: $35.51125 per GM · Effective Jan 01, 2021

Current Package Pricing Information

The latest wholesale acquisition cost for Bevespi Aerosphere (NDC 0310-4600-39) is $35.51125 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 01, 2021.

As a a human prescription drug provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 28 AEROSOL, METERED in 1 INHALER configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$35.51125
Per GM

Effective Date
Jan 01, 2021
Data Status
As of Jan 12, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
28 AEROSOL, METERED in 1 INHALER
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Mar 2017, the NADAC wholesale price for (NDC ) has moved within a range of $30.03431 to $40.98562 per GM. Over this 9 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$30.0343 - $40.9856
Market Volatility
36.46% Variance
Latest Trend
0.01%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $40.85993 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 19, 2026 $40.85775 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $40.87189 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $40.87579 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $40.86338 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $40.98562 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $40.98562 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $40.98562 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $39.79109 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $39.78815 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $39.78600 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $39.77958 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026